154 related articles for article (PubMed ID: 38804512)
1. Autoantibodies Targeting Nephrin in Podocytopathies.
Hengel FE; Dehde S; Lassé M; Zahner G; Seifert L; Schnarre A; Kretz O; Demir F; Pinnschmidt HO; Grahammer F; Lucas R; Mehner LM; Zimmermann T; Billing AM; Oh J; Mitrotti A; Pontrelli P; Debiec H; Dossier C; Colucci M; Emma F; Smoyer WE; Weins A; Schaefer F; Alachkar N; Diemert A; Hogan J; Hoxha E; Wiech T; Rinschen MM; Ronco P; Vivarelli M; Gesualdo L; Tomas NM; Huber TB;
N Engl J Med; 2024 May; ():. PubMed ID: 38804512
[TBL] [Abstract][Full Text] [Related]
2. Discovery of Autoantibodies Targeting Nephrin in Minimal Change Disease Supports a Novel Autoimmune Etiology.
Watts AJB; Keller KH; Lerner G; Rosales I; Collins AB; Sekulic M; Waikar SS; Chandraker A; Riella LV; Alexander MP; Troost JP; Chen J; Fermin D; Yee JL; Sampson MG; Beck LH; Henderson JM; Greka A; Rennke HG; Weins A
J Am Soc Nephrol; 2022 Jan; 33(1):238-252. PubMed ID: 34732507
[TBL] [Abstract][Full Text] [Related]
3. Nephrinuria and podocytopathies.
Kostovska I; Trajkovska KT; Topuzovska S; Cekovska S; Labudovic D; Kostovski O; Spasovski G
Adv Clin Chem; 2022; 108():1-36. PubMed ID: 35659057
[TBL] [Abstract][Full Text] [Related]
4. Review of the Role of Rituximab in the Management of Adult Minimal Change Disease and Immune-Mediated Focal and Segmental Glomerulosclerosis.
Aslam A; Koirala A
Glomerular Dis; 2023; 3(1):211-219. PubMed ID: 37901702
[TBL] [Abstract][Full Text] [Related]
5. An overview of molecular mechanism of nephrotic syndrome.
Machado JR; Rocha LP; Neves PD; Cobô Ede C; Silva MV; Castellano LR; Corrêa RR; Reis MA
Int J Nephrol; 2012; 2012():937623. PubMed ID: 22844593
[TBL] [Abstract][Full Text] [Related]
6. New Anti-Nephrin Antibody Mediated Podocyte Injury Model Using a C57BL/6 Mouse Strain.
Takeuchi K; Naito S; Kawashima N; Ishigaki N; Sano T; Kamata K; Takeuchi Y
Nephron; 2018; 138(1):71-87. PubMed ID: 28965116
[TBL] [Abstract][Full Text] [Related]
7. Reduced podocin expression in minimal change disease and focal segmental glomerulosclerosis is related to the level of proteinuria.
Agrawal V; Prasad N; Jain M; Pandey R
Clin Exp Nephrol; 2013 Dec; 17(6):811-8. PubMed ID: 23377573
[TBL] [Abstract][Full Text] [Related]
8. Targeted downregulation of extracellular nephrin in human IgA nephropathy.
Gagliardini E; Benigni A; Tomasoni S; Abbate M; Kalluri R; Remuzzi G
Am J Nephrol; 2003; 23(4):277-86. PubMed ID: 12853730
[TBL] [Abstract][Full Text] [Related]
9. Childhood nephrotic syndrome in tropical Africa: then and now.
Olowu WA; Ademola A; Ajite AB; Saad YM
Paediatr Int Child Health; 2017 Nov; 37(4):259-268. PubMed ID: 28949280
[TBL] [Abstract][Full Text] [Related]
10. Detection of urinary podocytes and nephrin as markers for children with glomerular diseases.
Wang P; Li M; Liu Q; Chen B; Ji Z
Exp Biol Med (Maywood); 2015 Feb; 240(2):169-74. PubMed ID: 25245074
[TBL] [Abstract][Full Text] [Related]
11. Spectrum of steroid-resistant and congenital nephrotic syndrome in children: the PodoNet registry cohort.
Trautmann A; Bodria M; Ozaltin F; Gheisari A; Melk A; Azocar M; Anarat A; Caliskan S; Emma F; Gellermann J; Oh J; Baskin E; Ksiazek J; Remuzzi G; Erdogan O; Akman S; Dusek J; Davitaia T; Özkaya O; Papachristou F; Firszt-Adamczyk A; Urasinski T; Testa S; Krmar RT; Hyla-Klekot L; Pasini A; Özcakar ZB; Sallay P; Cakar N; Galanti M; Terzic J; Aoun B; Caldas Afonso A; Szymanik-Grzelak H; Lipska BS; Schnaidt S; Schaefer F;
Clin J Am Soc Nephrol; 2015 Apr; 10(4):592-600. PubMed ID: 25635037
[TBL] [Abstract][Full Text] [Related]
12. A pilot study of anti-nephrin antibodies in podocytopaties among adults.
Chebotareva N; Vinogradov A; Birukova Y; Alentov I; Sergeeva N; Chemodanova D; Kononikhin AS; Moiseev SV
Nephrology (Carlton); 2024 Feb; 29(2):86-92. PubMed ID: 37864506
[TBL] [Abstract][Full Text] [Related]
13. Possible role of autoantibodies against nephrin in an experimental model of chronic graft-versus-host disease.
Nagahama K; Maru K; Kanzaki S; Chai HL; Nakai T; Miura S; Yamaguchi A; Yamanaka S; Nagashima Y; Aoki I
Clin Exp Immunol; 2005 Aug; 141(2):215-22. PubMed ID: 15996185
[TBL] [Abstract][Full Text] [Related]
14. Expression of podocyte-associated molecules in acquired human kidney diseases.
Koop K; Eikmans M; Baelde HJ; Kawachi H; De Heer E; Paul LC; Bruijn JA
J Am Soc Nephrol; 2003 Aug; 14(8):2063-71. PubMed ID: 12874460
[TBL] [Abstract][Full Text] [Related]
15. CD2-associated protein and glomerular disease.
Wolf G; Stahl RA
Lancet; 2003 Nov; 362(9397):1746-8. PubMed ID: 14643126
[TBL] [Abstract][Full Text] [Related]
16. Expression of nephrin in acquired human glomerular disease.
Huh W; Kim DJ; Kim MK; Kim YG; Oh HY; Ruotsalainen V; Tryggvason K
Nephrol Dial Transplant; 2002 Mar; 17(3):478-84. PubMed ID: 11865096
[TBL] [Abstract][Full Text] [Related]
17. Slit diaphragm dysfunction in proteinuric states: identification of novel therapeutic targets for nephrotic syndrome.
Kawachi H; Suzuki K; Miyauchi N; Hashimoto T; Otaki Y; Shimizu F
Clin Exp Nephrol; 2009 Aug; 13(4):275-280. PubMed ID: 19266252
[TBL] [Abstract][Full Text] [Related]
18. Nephrin Loss Can Be Used to Predict Remission and Long-term Renal Outcome in Patients With Minimal Change Disease.
van de Lest NA; Zandbergen M; IJpelaar DHT; Wolterbeek R; Bruijn JA; Bajema IM; Scharpfenecker M
Kidney Int Rep; 2018 Jan; 3(1):168-177. PubMed ID: 29340328
[TBL] [Abstract][Full Text] [Related]
19. Neph1 is reduced in primary focal segmental glomerulosclerosis, minimal change nephrotic syndrome, and corresponding experimental animal models of adriamycin-induced nephropathy and puromycin aminonucleoside nephrosis.
Hulkko J; Patrakka J; Lal M; Tryggvason K; Hultenby K; Wernerson A
Nephron Extra; 2014 Sep; 4(3):146-54. PubMed ID: 25404935
[TBL] [Abstract][Full Text] [Related]
20. Glomerulonephritis Histopathological Pattern Change.
AlYousef A; AlSahow A; AlHelal B; Alqallaf A; Abdallah E; Abdellatif M; Nawar H; Elmahalawy R
BMC Nephrol; 2020 May; 21(1):186. PubMed ID: 32423387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
